Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta‐analysis

Abstract Introduction Several landmark randomized‐controlled trials (RCTs) have demonstrated the efficacy of sodium‐glucose co‐transport 2 (SGLT2) inhibitors in reducing all‐cause mortality, cardiovascular (CV) mortality and heart failure (HF) hospitalizations. Much interest surrounds their mechanis...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Patrick Savage, Chris Watson, Jaimie Coburn, Brian Cox, Michael Shahmohammadi, David Grieve, Lana Dixon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2024-12-01
coleção:	ESC Heart Failure
Assuntos:	heart failure SGLT2 inhibitors cardiac imaging remodelling biomarkers
Acesso em linha:	https://doi.org/10.1002/ehf2.14993
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!